Cargando…
Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality in the world. Late diagnosis is one of the most significant reasons for the high mortality rate of lung cancer. The identification of microRNAs (miRNAs) has opened a new field for molecular diagnosis of cancer. The p...
Autores principales: | Zhang, Hui, Mao, Feng, Shen, Tuyang, Luo, Qingquan, Ding, Zhengping, Qian, Liqiang, Huang, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351202/ https://www.ncbi.nlm.nih.gov/pubmed/28356944 http://dx.doi.org/10.3892/ol.2016.5462 |
Ejemplares similares
-
Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
por: Li, Bo-sheng, et al.
Publicado: (2012) -
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012) -
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012) -
Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson’s Disease
por: Wu, Li, et al.
Publicado: (2022) -
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)